Related Experiment Video
Updated: Jun 17, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Drugs to treat fibromyalgia - the transatlantic difference
Abstract:
Fibromyalgia is a disorder characterized by chronic widespread musculoskeletal pain and stiffness. In 2007, the US FDA approved pregabalin as the first drug indicated for the management of fibromyalgia. Within 18 months, the agency had also approved duloxetine and milnacipran for the same indication. However, although these drugs are already marketed in Europe for other indications, the European regulatory authorities recently rejected extending approval for these three drugs for the treatment of fibromyalgia. This editorial discusses the possible reasons for this 'transatlantic difference'.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: MAOIs and Other Agents
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Antidepressant Drugs: Overview

